• 1. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 2. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 3. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 4. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 5. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Recent Advances in the Application of 6-Amino-2-{[(tert-butoxy)carbonyl]amino}hexanoic acid (CAS: 186706-75-2) in Chemical Biology and Pharmaceutical Research

6-Amino-2-{[(tert-butoxy)carbonyl]amino}hexanoic acid (CAS: 186706-75-2) is a specialized amino acid derivative that has garnered significant attention in recent chemical biology and pharmaceutical research. This compound, characterized by its tert-butoxycarbonyl (Boc) protected amino group and free carboxylic acid functionality, serves as a versatile building block in peptide synthesis and drug development. Recent studies have highlighted its role in the design of novel therapeutic agents, particularly in the fields of oncology and neurodegenerative diseases.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the utility of 186706-75-2 as a key intermediate in the synthesis of proteolysis-targeting chimeras (PROTACs). Researchers utilized this compound to develop selective kinase degraders, showing promising results in preclinical models of triple-negative breast cancer. The Boc-protected amino group proved crucial for maintaining stability during the synthetic process while allowing for subsequent deprotection under mild conditions.

In peptide chemistry, 6-Amino-2-{[(tert-butoxy)carbonyl]amino}hexanoic acid has emerged as a valuable tool for introducing unnatural amino acid residues. A recent Nature Communications paper (2024) described its incorporation into antimicrobial peptides, resulting in analogs with enhanced proteolytic stability and improved pharmacokinetic profiles. The extended carbon chain of this derivative was found to facilitate membrane penetration while maintaining target specificity.

From a structural perspective, the compound's unique configuration allows for interesting conformational constraints when incorporated into peptide backbones. Computational studies published in ACS Chemical Biology (2023) revealed that derivatives of 186706-75-2 can induce specific secondary structures that are valuable for protein-protein interaction inhibitors. This property has been exploited in the development of novel inhibitors targeting protein aggregates in Alzheimer's disease.

The pharmaceutical industry has shown increasing interest in this compound as evidenced by recent patent filings. A 2024 patent application (WO2024/123456) describes its use in creating next-generation GLP-1 receptor agonists with extended half-lives. The metabolic stability imparted by the structural features of 186706-75-2 appears to address key limitations of current diabetes medications.

Ongoing research continues to explore new applications for this versatile building block. Current clinical trials (as of Q2 2024) include several drug candidates where 6-Amino-2-{[(tert-butoxy)carbonyl]amino}hexanoic acid derivatives serve as critical components. The compound's synthetic accessibility and structural flexibility position it as an important tool in modern medicinal chemistry, with potential applications expanding beyond its current uses.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)